News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Conference News AHA 2021 Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown Yael L. Maxwell November 14, 2021